Verona Pharma to Report Second Quarter 2024 Financial Results and Provide Corporate Update
Verona Pharma plc (Nasdaq: VRNA) has announced it will report its financial results for the second quarter ended June 30, 2024, on Thursday, August 8, 2024. The company will also host an investment community conference call at 9:00 a.m. EDT / 2:00 p.m. BST to discuss these financial results and provide a corporate update.
To participate in the call, investors can dial +1-833-816-1396 (US callers) or +1-412-317-0489 (international callers) and ask to join the Verona Pharma call. A live webcast will be available on the Events and Presentations link on the Investors page of the company's website, with an audio replay accessible for 90 days.
Verona Pharma plc (Nasdaq: VRNA) ha annunciato che riporterà i suoi risultati finanziari per il secondo trimestre conclusosi il 30 giugno 2024, giovedì 8 agosto 2024. L'azienda ospiterà anche una conferenza telefonica con la comunità degli investitori alle 9:00 EDT / 14:00 BST per discutere di questi risultati finanziari e fornire un aggiornamento aziendale.
Per partecipare alla chiamata, gli investitori possono comporre il numero +1-833-816-1396 (chiamate dagli Stati Uniti) o +1-412-317-0489 (chiamate internazionali) e chiedere di unirsi alla chiamata di Verona Pharma. Sarà disponibile un webcast dal vivo nel link Eventi e Presentazioni nella pagina Investitori del sito web dell'azienda, con una registrazione audio accessibile per 90 giorni.
Verona Pharma plc (Nasdaq: VRNA) ha anunciado que reportará sus resultados financieros para el segundo trimestre que finalizó el 30 de junio de 2024, el jueves 8 de agosto de 2024. La compañía también llevará a cabo una conferencia telefónica con la comunidad inversora a las 9:00 a.m. EDT / 2:00 p.m. BST para discutir estos resultados financieros y proporcionar una actualización corporativa.
Para participar en la llamada, los inversores pueden marcar +1-833-816-1396 (llamadas desde EE. UU.) o +1-412-317-0489 (llamadas internacionales) y pedir unirse a la llamada de Verona Pharma. Habrá una transmisión por webcast en vivo en el enlace de Eventos y Presentaciones en la página de Inversores del sitio web de la compañía, con una grabación de audio accesible durante 90 días.
Verona Pharma plc (Nasdaq: VRNA)는 2024년 6월 30일로 끝난 두 번째 분기의 재무 결과를 2024년 8월 8일 목요일에 발표할 것이라고 발표했습니다. 회사는 또한 오전 9시 EDT / 오후 2시 BST에 투자자 커뮤니티와의 컨퍼런스 콜을 열어 이러한 재무 결과를 논의하고 기업 업데이트를 제공할 예정입니다.
전화에 참여하려면 투자자는 +1-833-816-1396 (미국 통화) 또는 +1-412-317-0489 (국제 통화)를 다이얼하고 Verona Pharma 전화에 참여할 수 있도록 요청하면 됩니다. 회사 웹사이트의 투자자 페이지에 있는 이벤트 및 프레젠테이션 링크에서 실시간 웹캐스트가 제공되며, 오디오 재생은 90일 동안 이용 가능합니다.
Verona Pharma plc (Nasdaq: VRNA) a annoncé qu'elle publiera ses résultats financiers pour le deuxième trimestre se terminant le 30 juin 2024, le jeudi 8 août 2024. L'entreprise organisera également une conférence téléphonique avec la communauté des investisseurs à 9h00 EDT / 14h00 BST pour discuter de ces résultats financiers et fournir une mise à jour de l'entreprise.
Pour participer à l'appel, les investisseurs peuvent composer le +1-833-816-1396 (appels depuis les États-Unis) ou le +1-412-317-0489 (appels internationaux) et demander à rejoindre l'appel de Verona Pharma. Un webcast en direct sera disponible dans le lien Événements et Présentations sur la page Investisseurs du site web de l'entreprise, avec un replay audio accessible pendant 90 jours.
Verona Pharma plc (Nasdaq: VRNA) hat angekündigt, dass es am Donnerstag, den 8. August 2024 seine finanziellen Ergebnisse für das am 30. Juni 2024 endende zweite Quartal veröffentlichen wird. Das Unternehmen wird auch eine Telefonkonferenz mit der Investoren-Community um 9:00 Uhr EDT / 14:00 Uhr BST abhalten, um diese finanziellen Ergebnisse zu diskutieren und ein Unternehmensupdate bereitzustellen.
Um an der Konferenz teilzunehmen, können Investoren +1-833-816-1396 (Anrufer aus den USA) oder +1-412-317-0489 (internationale Anrufer) wählen und um Teilnahme an dem Verona Pharma Anruf bitten. Ein Live-Webcast wird im Bereich Veranstaltungen und Präsentationen auf der Investorenseite der Unternehmenswebsite verfügbar sein, mit einem Audio-Replay, das für 90 Tage zugänglich ist.
- None.
- None.
LONDON and RALEIGH, N.C., July 25, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that it will report its financial results for the second quarter ended June 30, 2024 on Thursday, August 8, 2024 and host an investment community conference call at 9:00 a.m. EDT / 2:00 p.m. BST to discuss these financial results and provide a corporate update.
To participate, please dial one of the following numbers and ask to join the Verona Pharma call:
- +1-833-816-1396 for callers in the United States
- +1-412-317-0489 for international callers
A live webcast will be available on the Events and Presentations link on the Investors page of the Company’s website, www.veronapharma.com, and the audio replay will be available for 90 days.
For further information please contact:
| Verona Pharma plc | Tel: +1-844-341-9901 |
| Victoria Stewart, Senior Director of Investor Relations and Communications | IR@veronapharma.com |
| Argot Partners US Investor Enquiries | Tel: +1-212-600-1902 verona@argotpartners.com |
| Ten Bridge Communications International / US Media Enquiries | Tel: +1-312-523-5016 tbcverona@tenbridgecommunications.com |
| Leslie Humbel | |
About Verona Pharma
Verona Pharma is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of chronic respiratory diseases with significant unmet medical needs. OhtuvayreTM (ensifentrine) is the Company’s first commercial product and the first inhaled therapy for the maintenance treatment of COPD that combines bronchodilator and non-steroidal anti-inflammatory activities in one molecule. Ensifentrine has potential applications in non-cystic fibrosis bronchiectasis, cystic fibrosis, asthma and other respiratory diseases. For more information, please visit www.veronapharma.com.
FAQ
When will Verona Pharma (VRNA) report its Q2 2024 financial results?
What time is Verona Pharma's (VRNA) Q2 2024 earnings call scheduled for?
How can investors participate in Verona Pharma's (VRNA) Q2 2024 earnings call?
Where can I find the webcast for Verona Pharma's (VRNA) Q2 2024 earnings call?
